A Phase 2 clinical trial testing PIPE-307, an MS experimental therapy designed to promote myelin repair, failed to meet its ...

Contineum Therapeutics’ M1 receptor antagonist has failed to move the needle in a phase 2 vision test for patients with a common form of multiple sclerosis. | Contineum Therapeutics’ M1 receptor ...

Simultaneously measuring levels of two blood proteins may help monitor both disease activity and disability progression in ...

Shares of Contineum Therapeutics dipped by the double-digits late Thursday after investors learned of a clinical setback for ...

Contineum Therapeutics said a trial of its treatment for relapsing-remitting multiple sclerosis didn't meet its primary or secondary efficacy endpoints. The San Diego biopharmaceutical company said ...

METV"> If you're a Des Moines Water Works customer... keep an eye on your mail. Notices about lead service lines are being sent out. Lead exposure can lead to health problems... especially for ...

According to the general, if the US begins preparations for nuclear tests at the Nevada test site, Russia will know about it in advance, since "it is impossible to hide the transfer of various ...

STDcheck aims to provide a judgment- and hassle-free experience for people wanting to test for sexually transmitted infections (STIs). To use this service, you purchase the laboratory test you want at ...